#Japan #Tokyo #MitoGenic #MytoRubin #DyDo Group

Innovative Collaboration in Mitochondrial Research

MitoGenic Co., Ltd., a venture birthed from Gakuin University, has announced a collaborative research project with DyDo Group Holdings. This partnership will focus on the development of foods and beverages utilizing a new plant-derived component called MytoRubin. The research is set to commence in March 2026 and aims to bring scientific advancements to the consumer market through innovative food products.

The Essence of the Collaboration

This cooperative effort stems from extensive mitochondrial research conducted at Gakuin University. MitoGenic will work closely with the DyDo Group Future Co-Creation Research Institute, leveraging insights obtained from mitochondrial studies. The objective is to ascertain how MytoRubin can be applied in the realms of food and beverage. Mitochondria, widely recognized as the powerhouses of the cell, are crucial for energy production, and their dysfunction is linked to aging and various health complications.

Understanding MytoRubin

Founded in 2023, MitoGenic emerged from the diligent work of Professor Shigeru Yanagi from the Faculty of Science at Gakuin University. The company revolves around the innovative properties of MytoRubin, a mitochondrial activation component derived from plants. Research surrounding MytoRubin has shown promise in enhancing mitochondrial functions associated with age-related physiological changes. Initial findings suggest MytoRubin positively influences these transformations, as evidenced by ongoing studies involving cellular and disease models.

Investigating Applications in Food and Beverage

The DyDo Group Future Co-Creation Research Institute was established in March 2025, focusing on providing products that are beneficial for both mind and body. This initiative emphasizes open innovation, encouraging collaboration between startups and academic institutions to develop groundbreaking food products. The partnership with MitoGenic marks a significant step towards integrating mitochondrial research into accessible consumer goods.

MitoGenic’s accumulated research knowledge, combined with DyDo's expertise in food and drink development, stands to pioneer new avenues in the industry. The collaborative goal is to explore the extensive potential of MytoRubin in creating innovative dietary and beverage solutions that enhance the quality of life.

Significance of the Joint Research

As a university-originated venture, MitoGenic's mission revolves around translating scientific advancements into practical applications that benefit society. The foundational research conducted at Gakuin University not only holds academic value but also promises to contribute to the public’s well-being. This joint venture exemplifies an effort to bridge the gap between academia and society, bringing forth valuable research findings for everyday use.

MitoGenic remains committed to being a conduit for advancing university research into functional societal applications, ensuring that the impact of such studies resonates with the public.

About MitoGenic Co., Ltd.

MitoGenic, founded in April 2023, draws from the extensive research conducted by Professor Shigeru Yanagi at Gakuin University. The company specializes in developing anti-aging solutions centered around MytoRubin. Notable accolades include the Grand Prize at the 7th Healthcare Venture Award hosted by the Japan Anti-Aging Association, and recognition at the 2025 Crowdfunding Awards organized by CAMPFIRE. MitoGenic is also designated as a certified startup company by the Japan Anti-Aging Association.

Contact Details:

• - Company Name: MitoGenic Co., Ltd.
• - Representative: Keito Tanizaka
• - Location: 3-1-5 Takadanobaba, Shinjuku-ku, Tokyo
• - URL: https://mitogenic.jp/
• - Email: [email protected]

This remarkable collaboration signifies a proactive approach in the field of health and nutrition, promising to enrich the consumer landscape with scientifically-backed innovations.